Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach

被引:165
作者
Gius, D
Cui, HM
Bradbury, CM
Cook, J
Smart, DDK
Zhao, SP
Young, L
Brandenburg, SA
Hu, YL
Bisht, KS
Ho, AS
Mattson, D
Sun, LC
Munson, PJ
Chuang, EY
Mitchell, JB
Feinberg, AP [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Biol Mol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Genet, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA
[6] NCI, Radiat Oncol Branch, Radiat Oncol Sci Program,Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[7] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[8] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA
关键词
D O I
10.1016/j.ccr.2004.08.029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We tested the hypothesis that the effects on gene expression of altered DNA methylation by 5-aza-2'-deoxycytidine (5-aza-CdR) and genetic (DNMT knockout) manipulation of DNA are similar, and distinct from Trichostatin A (TSA)-induced chromatin decondensation. Surprisingly, the effects of 5-aza-CdR were more similar to those of TSA than to DNMT1, DNMT3B, or double DNMT somatic cell knockout. Furthermore, the effects of 5-aza-CdR were similar at one and five days exposure, suggesting active demethylation or direct influence of both drugs on the stability of methylation and/or chromatin marks. Agents that induce gene activation through hypomethylation may have unintended consequences, since nearly as many genes were downregulated as upregulated after demethylation. In addition, a 75 kb cluster of metallothionein genes was coordinately regulated.
引用
收藏
页码:361 / 371
页数:11
相关论文
共 42 条
[1]   The protein CTCF is required for the enhancer blocking activity of vertebrate insulators [J].
Bell, AC ;
West, AG ;
Felsenfeld, G .
CELL, 1999, 98 (03) :387-396
[2]   The DNA methyltransferases of mammals [J].
Bestor, TH .
HUMAN MOLECULAR GENETICS, 2000, 9 (16) :2395-2402
[3]   Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma [J].
Carvalho, R ;
Kayademir, T ;
Soares, P ;
Canedo, P ;
Sousa, S ;
Oliveira, C ;
Leistenschneider, P ;
Seruca, R ;
Gött, P ;
Blin, N ;
Carneiro, F ;
Machado, JC .
LABORATORY INVESTIGATION, 2002, 82 (10) :1319-1326
[4]  
Chuang YYE, 2002, CANCER RES, V62, P6246
[5]   Modulation of plasmid DNA methylation and expression in zebrafish embryos [J].
Collas, P .
NUCLEIC ACIDS RESEARCH, 1998, 26 (19) :4454-4461
[6]   Loss of IGF2 imprinting:: A potential marker of colorectal cancer risk [J].
Cui, HM ;
Cruz-Correa, M ;
Giardiello, FM ;
Hutcheon, DF ;
Kafonek, DR ;
Brandenburg, S ;
Wu, YQ ;
He, XB ;
Powe, NR ;
Feinberg, AP .
SCIENCE, 2003, 299 (5613) :1753-1755
[7]  
Cui HM, 2001, CANCER RES, V61, P4947
[8]   Epigenetics in human disease and prospects for epigenetic therapy [J].
Egger, G ;
Liang, GN ;
Aparicio, A ;
Jones, PA .
NATURE, 2004, 429 (6990) :457-463
[9]  
Eisen MB, 1999, METHOD ENZYMOL, V303, P179
[10]   Demethylation of the Epstein-Barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent - Brief Report [J].
Falk, KI ;
Ernberg, I .
ARCHIVES OF VIROLOGY, 1999, 144 (11) :2219-2227